Eupraxia Pharmaceuticals announced that three abstracts from its ongoing Phase 1b/2 RESOLVE trial of EP-104GI, a treatment for eosinophilic esophagitis (EoE), will be presented at the American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) conferences in October 2026. The data highlight improvements in dysphagia symptoms and histopathological features lasting up to 52 weeks after a single administration of EP-104GI. The RESOLVE trial is evaluating safety, tolerability, and efficacy of this locally delivered drug via esophageal injections. Eupraxia plans to release additional data soon, with interim Phase 2b results expected in December 2026. This development is significant as EoE is a growing inflammatory condition with limited treatment options.
Eupraxia Pharmaceuticals' upcoming presentations at major gastroenterology conferences provide context for health sector activity on Pluang as of Oct 09, 2026 17:51 WIB. Among 128 priced US health stocks, 66 advanced and 56 declined. Humana Inc (HUM) surged 14.24% to USD 442.25 with a typical hold time of 53 days, contrasting with Nuvation Bio Inc (NUVB) which rose 5.45% to USD 5.22 but sees zero days typical hold time, while Ginkgo Bioworks Holdings (DNA) gained 7.67% to USD 12.21, with a near even Pluang order split and a 7-day hold time.
At Malaysia's IGEM 2026, Sigenergy showcased its latest AI-driven energy technologies, including smart storage and inverter systems, highlighting its role in advancing sustainable energy. The company also signed MOUs with local partners Milieu and YT...
In 2026, Bitcoin has experienced 10 unusually large daily price moves of at least three standard deviations through October 9, surpassing the eight such moves recorded during the entire 2018 bear market. This is notable because overall annualized vol...
In 2026, Bitcoin's average annualized volatility has decreased to 40-47%, much lower than historical levels above 80%, suggesting calmer daily price movements. However, extreme price jumps—sudden large swings—have increased by 71% compared to 2018, i...
Hyperliquid will perform a network upgrade on October 10 at 4:15 a.m. ET, expected to last about 10 minutes. During this time, trading and on-chain activities may be temporarily interrupted. The maintenance is planned for early Saturday morning in th...
On October 9, Bitcoin spot ETFs attracted $21.13 million in net inflows, led by IBIT with $22.38 million, while Ether spot ETFs experienced $56.10 million in net outflows, marking nine straight sessions of decline. This divergence occurs amid ongoing...
